• KARM
  • Contact us
  • E-Submission
ABOUT
ARTICLE TYPES
BROWSE ARTICLES
AUTHOR INFORMATION

Page Path

4
results for

"Mi Ri Suh"

Filter

Article category

Keywords

Publication year

Authors

"Mi Ri Suh"

Original Articles
Improvement of Peak Cough Flow After the Application of a Mechanical In-exsufflator in Patients With Neuromuscular Disease and Pneumonia: A Pilot Study
Ji Ho Jung, Hyeon Jun Oh, Jang Woo Lee, Mi Ri Suh, Jihyun Park, Won Ah Choi, Seong-Woong Kang
Ann Rehabil Med 2018;42(6):833-837.   Published online December 28, 2018
DOI: https://doi.org/10.5535/arm.2018.42.6.833
Objective
To investigate and demonstrate persistent increase of peak cough flow after mechanical in-exsufflator application, in patients with neuromuscular diseases and pneumonia.
Methods
A mechanical in-exsufflator was applied with patients in an upright or semi-upright sitting position (pressure setting, +40 and −40 cmH2O; in-exsufflation times, 2–3 and 1–2 seconds, respectively). Patients underwent five cycles, with 20–30 second intervals to prevent hyperventilation. Peak cough flow without and with assistive maneuvers, was evaluated before, and 15 and 45 minutes after mechanical in-exsufflator application.
Results
Peak cough flow was 92.6 L/min at baseline, and 100.4 and 100.7 L/min at 15 and 45 minutes after mechanical in-exsufflator application, respectively. Assisted peak cough flow at baseline, 15 minutes, and 45 minutes after mechanical in-exsufflator application was 170.7, 179.3, and 184.1 L/min, respectively. While peak cough flow and assisted peak cough flow increased significantly at 15 minutes after mechanical in-exsufflator application compared with baseline (p=0.030 and p=0.016), no statistical difference was observed between 15 and 45 minutes.
Conclusion
Increased peak cough flow after mechanical in-exsufflator application persists for at least 45 minutes.

Citations

Citations to this article as recorded by  
  • Physiological Effects of Mechanical Insufflation-Exsufflation in Patients With Neuromuscular Disease: A Scoping Review
    Lisa Edel, Tiina Andersen, Emma Shkurka
    Respiratory Care.2025;[Epub]     CrossRef
  • Pearls and pitfalls of respiratory testing in a patient with amyotrophic lateral sclerosis and COPD
    Stephen W. Littleton, Franco Laghi
    Breathe.2023; 19(2): 230043.     CrossRef
  • The use of cough peak flow in the assessment of respiratory function in clinical practice- A narrative literature review
    M. Brennan, M.J. McDonnell, N. Duignan, F. Gargoum, R.M. Rutherford
    Respiratory Medicine.2022; 193: 106740.     CrossRef
  • Comparison of two mechanical insufflation-exsufflation devices in patients with amyotrophic lateral sclerosis: a preliminary study
    Antonello NICOLINI, Paola PRATO, Laura BECCARELLI, Bruna GRECCHI, Giancarlo GARUTI, Paolo BANFI, Francesco D’ABROSCA
    Panminerva Medica.2022;[Epub]     CrossRef
  • Analysis of Pneumothorax in Noninvasive Ventilator Users With Duchenne Muscular Dystrophy
    Han Eol Cho, Justin Byun, Won Ah Choi, Myungsang Kim, Kyeong Yeol Kim, Seong-Woong Kang
    Chest.2021; 159(4): 1540.     CrossRef
  • 9,239 View
  • 180 Download
  • 6 Web of Science
  • 5 Crossref
Long-Term Outcome of Amyotrophic Lateral Sclerosis in Korean Subjects
Mi Ri Suh, Won Ah Choi, Young-Chul Choi, Jang Woo Lee, Jung Hwa Hong, Jihyun Park, Seong-Woong Kang
Ann Rehabil Med 2017;41(6):1055-1064.   Published online December 28, 2017
DOI: https://doi.org/10.5535/arm.2017.41.6.1055
Objective

To report the latest long-term outcome of amyotrophic lateral sclerosis (ALS) and to analyze the predictors of prognosis.

Methods

Subjects who were diagnosed with ALS between January 2005 and December 2009 at a single institute were followed up until death or up to December 2014. Data regarding age, sex, date of onset, date of diagnosis, presence of bulbar symptoms on onset, date of initiation of non-invasive ventilation (NIV), and the date of tracheostomy were collected. Survival was assessed using Kaplan-Meier curves and multivariate analyses of the risk of death were performed using the Cox proportional hazards model.

Results

Among 212 suspicious subjects, definite ALS was diagnosed in 182 subjects. The survival rate at 3 and 5 years from onset was 61.5% and 40.1%, respectively, and the survival rate at 3 and 5 years post-diagnosis was 49.5% and 24.2%, respectively. Further, 134 patients (134/182, 73.6%) were initiated on NIV, and among them, 90 patients (90/182, 49.5%) underwent tracheostomy. Male gender and onset age of ≥65 years were independent predictors of adverse survival.

Conclusion

The analysis of long term survival in ALS showed excellent outcomes considering the overall poor prognosis of this disease.

Citations

Citations to this article as recorded by  
  • A fact‐finding survey of medical care provided to neuromuscular disease patients at the National Center of Neurology and Psychiatry in Japan
    Akiko Hanai, Keisuke Yorimoto, Ryo Ohkubo, Tadashi Tsukamoto, Katsuhiro Mizuno, Yuji Takahashi
    Neurology and Clinical Neuroscience.2023; 11(1): 32.     CrossRef
  • Interleukin 6 (IL6) level is a biomarker for functional disease progression within IL6R358Ala variant groups in amyotrophic lateral sclerosis patients
    Marlena Wosiski-Kuhn, James B. Caress, Michael S. Cartwright, Gregory A. Hawkins, Carol Milligan
    Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration.2021; 22(3-4): 248.     CrossRef
  • What is the Adequate Cuff Volume for Tracheostomy Tube? A Pilot Cadaver Study
    Dong Min Kim, Myung Jun Shin, Sung Dong Kim, Yong Beom Shin, Ho Eun Park, Young Mo Kim, Jin A Yoon
    Annals of Rehabilitation Medicine.2020; 44(5): 402.     CrossRef
  • 10,001 View
  • 121 Download
  • 3 Web of Science
  • 3 Crossref
Correlation of Serum Creatine Kinase Level With Pulmonary Function in Duchenne Muscular Dystrophy
Eun Young Kim, Jang Woo Lee, Mi Ri Suh, Won Ah Choi, Seong Woong Kang, Hyeon Jun Oh
Ann Rehabil Med 2017;41(2):306-312.   Published online April 27, 2017
DOI: https://doi.org/10.5535/arm.2017.41.2.306
Objective

To investigate the relationship between serum creatine kinase (CK) level and pulmonary function in Duchenne muscular dystrophy (DMD).

Methods

A total of 202 patients with DMD admitted to the Department of Rehabilitation Medicine, Gangnam Severance Hospital were enrolled from January 1, 1999 to March 31, 2015. Seventeen patients were excluded. Data collected from the 185 patients included age, height, weight, body mass index, pulmonary function tests including forced vital capacity (FVC), peak cough flow, maximal expiratory pressure (MEP), and maximal inspiratory pressure (MIP), and laboratory measurements (serum level of CK, CK-MB, troponin-T, and B-type natriuretic peptide). FVC, MEP, and MIP were expressed as percentages of predicted normal values.

Results

Serum CK activities were elevated above normal levels, even in the oldest DMD group. Serum CK level was strongly correlated with pulmonary functions of sitting FVC (p<0.001), supine FVC (p<0.001), MIP (p=0.004), and MEP (p<0.001).

Conclusion

Serum CK level is a reliable screening test even in patients with advanced DMD, and is a strong predictor of pulmonary functions.

Citations

Citations to this article as recorded by  
  • Cardiac and skeletal muscle delivery of biotherapeutics with a blood vessel epicardial substance-targeting peptide
    Biaobiao Wang, Jiahui Cao, Jingqiao Wu, Yiwen Zhao, Yao Zhang, Frank Abendroth, Caorui Lin, Li Zhong, Huanan Yu, Yiqi Seow, Meitong Ou, Olalla Vázquez, Lin Mei, HaiFang Yin, Gang Han
    Biomaterials.2026; 329: 123986.     CrossRef
  • Orthopaedic Management in Duchenne Muscular Dystrophy
    Uma Balachandran, Taylor Mustapich, Sheena C. Ranade
    Journal of the Pediatric Orthopaedic Society of North America.2025; 10: 100154.     CrossRef
  • Fighting for every beat: cardiac therapies in Duchenne muscular dystrophy
    Antoine Muchir
    Skeletal Muscle.2025;[Epub]     CrossRef
  • In Vivo Phage Display for the Identification of Muscle Homing Peptides to Improve the Delivery of Phosphorodiamidate Morpholino Oligomers for Duchenne Muscular Dystrophy Therapy
    Anne-Fleur E. Schneider, Christa L. Tanganyika-de Winter, Hailiang Mei, Silvana M.G. Jirka, Xuyu Tan, Emily G. Thompson, Kristin Ha, Anindita Mitra, Stephanie Garcia, Marleen Luimes, Ryan Oliver, Kathy Y. Morgan, Vincent Guerlavais, Annemieke Aartsma-Rus
    Nucleic Acid Therapeutics.2025; 35(5): 220.     CrossRef
  • Statistical Genetics of DMD Gene Mutations in a Kazakhstan Cohort: MLPA/NGS Variant Validation and Genotype–Phenotype Modelling
    Aizhan Moldakaryzova, Dias Dautov, Saken Khaidarov, Saniya Ossikbayeva, Dilyara Kaidarova
    Genes.2025; 17(1): 20.     CrossRef
  • N-terminal titin fragment: a non-invasive, pharmacodynamic biomarker for microdystrophin efficacy
    Jessica F. Boehler, Kristy J. Brown, Valeria Ricotti, Carl A. Morris
    Skeletal Muscle.2024;[Epub]     CrossRef
  • Personalized and muscle-specific OXPHOS measurement with integrated CrCEST MRI and proton MR spectroscopy
    Ryan R. Armbruster, Dushyant Kumar, Blake Benyard, Paul Jacobs, Aditi Khandavilli, Fang Liu, Ravi Prakash Reddy Nanga, Shana McCormack, Anne R. Cappola, Neil Wilson, Ravinder Reddy
    Nature Communications.2024;[Epub]     CrossRef
  • Synthetic datasets for open software development in rare disease research
    Ibraheem Al-Dhamari, Hammam Abu Attieh, Fabian Prasser
    Orphanet Journal of Rare Diseases.2024;[Epub]     CrossRef
  • Unveiling the Respiratory Muscle Strength in Duchenne Muscular Dystrophy: The Impact of Nutrition and Thoracic Deformities, Beyond Spirometry
    Mine Yuksel Kalyoncu, Yasemin Gokdemir, Cansu Yilmaz Yegit, Muruvvet Yanaz, Aynur Gulieva, Merve Selcuk, Şeyda Karabulut, Neval Metin Çakar, Pinar Ergenekon, Ela Erdem Eralp, Gülten Öztürk, Olcay Unver, Dilsad Turkdogan, Yavuz Sahbat, Ahmet Hamdi Akgülle,
    Children.2024; 11(8): 994.     CrossRef
  • Duchenne Muscular Dystrophy in Two Half-Brothers Due to Inherited 306 Kb Inverted Insertion of 10p15.1 into Intron 44 of the Dp427m Transcript of the DMD Gene
    Wayne M. Jepsen, Andrew Fazenbaker, Keri Ramsey, Anna Bonfitto, Marcus Naymik, Bryce Turner, Jennifer Sloan, Nishant Tiwari, Saunder M. Bernes, Derek E. Neilson, Meredith Sanchez-Castillo, Matt J. Huentelman, Vinodh Narayanan
    International Journal of Molecular Sciences.2024; 25(22): 11922.     CrossRef
  • Chronic granulomatous disease associated with Duchenne muscular dystrophy caused by Xp21.1 contiguous gene deletion syndrome: Case report and literature review
    Shaohua Bi, Liying Dai, Liangliang Jiang, Lili Wang, Mia Teng, Guanghui Liu, Ru-Jeng Teng
    Frontiers in Genetics.2023;[Epub]     CrossRef
  • Urine titin as a novel biomarker for Duchenne muscular dystrophy
    Misawa Niki Ishii, Masato Nakashima, Hidenori Kamiguchi, Neta Zach, Ryosuke Kuboki, Rina Baba, Takeshi Hirakawa, Kazunori Suzuki, Maria Quinton
    Neuromuscular Disorders.2023; 33(4): 302.     CrossRef
  • Creatine Kinase Is Decreased in Childhood Asthma
    Stefano Guerra, Julie G. Ledford, Erik Melén, Iris Lavi, Anne-Elie Carsin, Debra A. Stern, Jing Zhai, Marta Vidal, Mariona Bustamante, Kenneth J. Addison, Renata G. Vallecillo, Dean Billheimer, Gerard H. Koppelman, Judith Garcia-Aymerich, Nathanaël Lemonn
    American Journal of Respiratory and Critical Care Medicine.2023; 207(5): 544.     CrossRef
  • Advances in Dystrophinopathy Diagnosis and Therapy
    Fawzy A. Saad, Gabriele Siciliano, Corrado Angelini
    Biomolecules.2023; 13(9): 1319.     CrossRef
  • MOTS‐c promotes phosphorodiamidate morpholino oligomer uptake and efficacy in dystrophic mice
    Ning Ran, Caorui Lin, Ling Leng, Gang Han, Mengyuan Geng, Yingjie Wu, Scott Bittner, Hong M Moulton, HaiFang Yin
    EMBO Molecular Medicine.2021;[Epub]     CrossRef
  • RESPIRATORY MUSCLE IMPAIRMENT EVALUATED WITH MEP/MIP RATIO IN CHILDREN AND ADOLESCENTS WITH CHRONIC RESPIRATORY DISEASE
    Iván Rodríguez-Núñez, Gerardo Torres, Soledad Luarte-Martinez, Carlos Manterola, Daniel Zenteno
    Revista Paulista de Pediatria.2021;[Epub]     CrossRef
  • A Blood Biomarker for Duchenne Muscular Dystrophy Shows That Oxidation State of Albumin Correlates with Protein Oxidation and Damage in Mdx Muscle
    Basma A. Al-Mshhdani, Miranda D. Grounds, Peter G. Arthur, Jessica R. Terrill
    Antioxidants.2021; 10(8): 1241.     CrossRef
  • High‑dose intravenous immunoglobulins as a therapeutic option in critical illness polyneuropathy accompanying SARS‑CoV‑2 infection: A case‑based review of the literature (Review)
    Adina Stoian, Zoltan Bajko, Smaranda Maier, Roxana Cioflinc, Bianca Grigorescu, Anca Moțățăianu, Laura Bărcuțean, Rodica Balașa, Mircea Stoian
    Experimental and Therapeutic Medicine.2021;[Epub]     CrossRef
  • Intensive Care Unit-Acquired Weakness: Not Just Another Muscle Atrophying Condition
    Heta Lad, Tyler M. Saumur, Margaret S. Herridge, Claudia C. dos Santos, Sunita Mathur, Jane Batt, Penney M. Gilbert
    International Journal of Molecular Sciences.2020; 21(21): 7840.     CrossRef
  • Proteomic serum biomarkers for neuromuscular diseases
    Sandra Murphy, Margit Zweyer, Rustam R. Mundegar, Dieter Swandulla, Kay Ohlendieck
    Expert Review of Proteomics.2018; 15(3): 277.     CrossRef
  • Necroptosis mediates myofibre death in dystrophin-deficient mice
    Jennifer E. Morgan, Alexandre Prola, Virginie Mariot, Veronica Pini, Jinhong Meng, Christophe Hourde, Julie Dumonceaux, Francesco Conti, Frederic Relaix, Francois-Jerôme Authier, Laurent Tiret, Francesco Muntoni, Maximilien Bencze
    Nature Communications.2018;[Epub]     CrossRef
  • LIMB GIRDLE MUSCULAR DYSTROPHY IN EARLY CHILDHOOD- CLINICAL HETEROGENEITY AND CLUE TO EARLY DIAGNOSIS
    Beena Vasanthy, Vijayan Chandrathil Parameswaran Nair
    Journal of Evidence Based Medicine and Healthcare.2018; 5(41): 2907.     CrossRef
  • Immunobiology of Inherited Muscular Dystrophies
    James G. Tidball, Steven S. Welc, Michelle Wehling‐Henricks
    Comprehensive Physiology.2018; 8(4): 1313.     CrossRef
  • Comparative Analysis of Serum Proteins from Patients with Severe and Mild EV‐A71‐induced HFMD using iTRAQ‐Coupled LC‐MS/MS Screening
    Peihu Fan, Wei Chen, Pin Yu, Linlin Bao, Lili Xu, Chuan Qin
    PROTEOMICS – Clinical Applications.2017;[Epub]     CrossRef
  • 18,132 View
  • 117 Download
  • 24 Web of Science
  • 24 Crossref
Ultrasound-Guided Myofascial Trigger Point Injection Into Brachialis Muscle for Rotator Cuff Disease Patients With Upper Arm Pain: A Pilot Study
Mi Ri Suh, Won Hyuk Chang, Hyo Seon Choi, Sang Chul Lee
Ann Rehabil Med 2014;38(5):673-681.   Published online October 30, 2014
DOI: https://doi.org/10.5535/arm.2014.38.5.673
Objective

To assess the efficacy of trigger point injection into brachialis muscle for rotator cuff disease patients with upper arm pain.

Methods

A prospective, randomized, and single-blinded clinical pilot trial was performed at university rehabilitation hospital. Twenty-one patients clinically diagnosed with rotator cuff disease suspected of having brachialis myofascial pain syndrome (MPS) were randomly allocated into two groups. Effect of ultrasound (US)-guided trigger point injection (n=11) and oral non-steroidal anti-inflammatory drug (NSAID) (n=10) was compared by visual analog scale (VAS).

Results

US-guided trigger point injection of brachialis muscle resulted in excellent outcome compared to the oral NSAID group. Mean VAS scores decreased significantly after 2 weeks of treatment compared to the baseline in both groups (7.3 vs. 4.5 in the injection group and 7.4 vs. 5.9 in the oral group). The decrease of the VAS score caused by injection (ДVAS=-2.8) was significantly larger than caused by oral NSAID (ДVAS=-1.5) (p<0.05).

Conclusion

In patients with rotator cuff disease, US-guided trigger point injection of the brachialis muscle is safe and effective for both diagnosis and treatment when the cause of pain is suspected to be originated from the muscle.

Citations

Citations to this article as recorded by  
  • An Overview of Invasive Pain Management Treatments Including Regenerative Approaches
    Mustafa Y. Broachwala, Niketa N. Parikh, Christopher Anderson, Nathaniel M. Schuster
    Neurologic Clinics.2025; 43(3): 517.     CrossRef
  • Comparison of dry needling and kinesio taping® in management of latent trapezius myofascial trigger points
    Vahid Mazloum, Abolfazl Shakibaee
    Sport Sciences for Health.2023; 19(2): 479.     CrossRef
  • BIOMECHANICAL AND THERAPEUTIC IMPLICATIONS OF THE ANATOMICAL LOCATION OF TRIGGER POINTS
    Bogdan-Alexandru HAGIU
    Studia Universitatis Babeş-Bolyai Educatio Artis Gymnasticae.2023; : 105.     CrossRef
  • Letter to the Editor: Is Using Ultrasound Necessary or Obligatory During Needling Biceps Brachii? An Important Neuroanatomical Site
    Burak Tayyip Dede, Fatih Bağcıer
    Medical Acupuncture.2023; 35(5): 273.     CrossRef
  • Trigger Point Injections Versus Medical Management for Acute Myofascial Pain: A Systematic Review and Meta-Analysis
    Haroutiun Hamzoian, Vahe Zograbyan
    Cureus.2023;[Epub]     CrossRef
  • Pressure pain sensitivity, thermographic changes, function, life and sleep quality in patients with unilateral rotator cuff injury: A case-control study
    Faruk Tanık, Merve Keskin, Derya Özer Kaya
    Musculoskeletal Science and Practice.2023; 67: 102860.     CrossRef
  • Effects of ischemic compression and instrument-assisted soft tissue mobilization techniques in trigger point therapy in patients with rotator cuff pathology: randomized controlled study
    Busra Aksan Sadikoglu, Yildiz Analay Akbaba, Hanifegul Taskiran
    Somatosensory & Motor Research.2022; 39(1): 70.     CrossRef
  • Ultrasound-guided interventional procedures for myofascial trigger points: a systematic review
    Dion Diep, Kevin Jia Qi Chen, Dinesh Kumbhare
    Regional Anesthesia & Pain Medicine.2021; 46(1): 73.     CrossRef
  • Ultrasound-guided dextrose solution perimysium dissection for posterior shoulder myofascial pain
    Yi-Chen Lai, Sheng-Han Tsai, Hong-Jen Chiou
    Journal of the Chinese Medical Association.2021; 84(6): 650.     CrossRef
  • The effectiveness of trigger point treatment in rotator cuff pathology: A randomized controlled double-blind study
    Yildiz Analay Akbaba, Ebru Kaya Mutlu, Suleyman Altun, Ezgi Turkmen, Tansu Birinci, Derya Celik
    Journal of Back and Musculoskeletal Rehabilitation.2019; 32(3): 519.     CrossRef
  • The local twitch response during trigger point dry needling: Is it necessary for successful outcomes?
    Thomas Perreault, James Dunning, Raymond Butts
    Journal of Bodywork and Movement Therapies.2017; 21(4): 940.     CrossRef
  • Characteristics of Myofascial Pain Syndrome of the Infraspinatus Muscle
    Junbeom Kwon, Hyoung Seop Kim, Won Hyuk Chang, Chunung Park, Sang Chul Lee
    Annals of Rehabilitation Medicine.2017; 41(4): 573.     CrossRef
  • Management of chronic shoulder pain with restricted mobility - a case series
    Deepak Thapa, Vanita Ahuja, Deepanshu Dhiman
    Indian Journal of Anaesthesia.2016; 60(11): 858.     CrossRef
  • Analgesic efficacy of ultrasound identified trigger point injection in myofascial pain syndrome: A pilot study in Indian patients
    S Parthasarathy, SAntony John Charles
    Indian Journal of Pain.2016; 30(3): 162.     CrossRef
  • Short-Term Effects of Kinesio Taping and Cross Taping Application in the Treatment of Latent Upper Trapezius Trigger Points: A Prospective, Single-Blind, Randomized, Sham-Controlled Trial
    Tomasz Halski, Kuba Ptaszkowski, Lucyna Słupska, Małgorzata Paprocka-Borowicz, Robert Dymarek, Jakub Taradaj, Gabriela Bidzińska, Daniel Marczyński, Aleksandra Cynarska, Joanna Rosińczuk
    Evidence-Based Complementary and Alternative Medicine.2015; 2015: 1.     CrossRef
  • A critical evaluation of Quintner et al: Missing the point
    Jan Dommerholt, Robert D. Gerwin
    Journal of Bodywork and Movement Therapies.2015; 19(2): 193.     CrossRef
  • 9,748 View
  • 119 Download
  • 14 Web of Science
  • 16 Crossref
TOP